Stock GALENA BIOPHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Galena Biopharma Inc Nasdaq

Equities

US3632561086

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Galena Biopharma Inc
Apr. 03 North American Morning Briefing : Powell Awaited -2- DJ
Mar. 28 SELLAS Life Sciences Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Galena Biopharma Inc

fd10d.hEOTIQ256d8kJ4osE12mVoW1qsVCl4MOotsrTH939pU.zRnVblWAiqtWRu10UifVIbXv3ZYG-81nwbwSNjcOkKzUG6ZmT9ea7VRW_Q~5fe48ffbdee8366a7248217091c870bc

Upcoming events on Galena Biopharma Inc

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-13 Q3 2024 Earnings Release (Projected)
2025-03-19 Q4 2024 Earnings Release (Projected)

Past events on Galena Biopharma Inc

2024-03-28 04:05 pm Q4 2023 Earnings Release
2024-03-26 08:15 am Business Update Call
2024-03-03 06:00 am European School of Haematology Acute Leukaemias Conference - Abstract No:6192705
2024-01-03 08:30 am Business Update Call
2023-11-23 07:00 am Annual General Meeting
2023-11-09 04:04 pm Q3 2023 Earnings Release
2023-11-04 Global Meeting of the International Gynecologic Cancer Society
2023-09-27 09:10 am Cantor Global Healthcare Conference
2023-08-10 04:08 pm Q2 2023 Earnings Release
2023-06-21 09:30 am Maxim Group Virtual Healthcare Conference - Fireside Chat
2023-06-20 08:30 am Annual General Meeting
2023-06-05 09:00 am American Society of Clinical Oncology Conference - Abstract No : TPS7074
2023-05-30 08:00 am Business Update Call
2023-05-11 04:12 pm Q1 2023 Earnings Release
2023-03-16 04:11 pm Q4 2022 Earnings Release
2023-01-31 08:30 am Investor Meeting - Key Opinion Leader:Galinpepimut-S
2022-12-12 American Society of Hematology Meeting - Abstract #: 4263
2022-12-11 American Society of Hematology Meeting - Abstract #: 3477
2022-12-07 03:20 pm JMP Securities Hematology Oncology Summit
2022-11-14 08:30 am REGAL Phase 3 Clinical Trial Update Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		1,90
0,00
- 		7,60
5,07
50%		1,00
1,00
0%		0,00
13,0
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-17,2
-15,7
-9.7%		-17,0
-16,9
-0.39%		-25,3
-24,3
-4.19%		-42,0
-37,7
-11.17%		-37,9
-30,3
-24.83%
-39,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-19,4
-14,4
-34.79%		-16,8
-17,2
2.64%		-20,9
-23,4
10.57%		-41,3
-39,6
-4.25%		-37,3
-25,8
-44.54%
-40,0

Net income
Million USD		Released
Forecast
Spread 		-28,0
-19,4
-43.97%		-16,8
-17,3
2.41%		-20,7
-21,1
2.04%		-41,3
-39,6
-4.25%		-37,3
-29,8
-25.2%
-40,0

EPS
USD		Released
Forecast
Spread 		-10,9
-9,71
-12.52%		-2,11
-1,83
-15.3%		-1,34
-1,34
-0.19%		-2,13
-2,10
-1.55%		-1,34
-1,10
-21.82%
-1,14

Announcement Date13/03/2023/03/2131/03/2216/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		1,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
13,0
- 		0,00
13,0
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-11,6
-7,03
-65.32%		-6,74
-6,77
0.56%		-8,62
-7,39
-16.66%		-7,15
-8,00
10.71%		-9,45
-7,38
-27.96%		-11,3
-8,56
-31.86%		-8,84
-9,63
8.16%		-9,36
0,70
-1443.52%		-8,18
-0,64
-1168.4%
-10,0


-10,2


-10,4


-10,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,84
-6,95
1.72%		-16,7
-6,22
-169.41%		-8,41
-7,27
-15.7%		-7,02
-8,00
12.26%		-9,12
-7,17
-27.29%		-11,1
-8,51
-30.36%		-8,84
-9,56
7.49%		-9,27
0,73
-1368.15%		-8,14
3,37
-341.39%
-9,95


-9,96


-10,2


-10,5

Net income
Million USD		Released
Forecast
Spread 		-6,60
-6,95
5.12%		-16,7
-6,22
-169.41%		-8,41
-7,27
-15.7%		-7,02
-8,00
12.26%		-9,12
-7,17
-27.29%		-11,1
-8,51
-30.36%		-8,84
-9,56
7.49%		-9,27
0,73
-1368.15%		-8,14
3,37
-341.39%
-9,95


-9,96


-10,2


-10,5

EPS
USD		Released
Forecast
Spread 		-0,42
-0,40
-4.13%		-1,05
-0,38
-176.32%		-0,41
-0,39
-5.13%		-0,34
-0,39
12.07%		-0,43
-0,32
-34.38%		-0,47
-0,29
-62.07%		-0,31
-0,36
12.68%		-0,33
0,02
-1985.71%		-0,25
-0,03
-837.38%
-8,13


-0,20


-0,20


-0,19

Announcement Date31/03/2212/05/2211/08/2214/11/2216/03/2311/05/2310/08/2309/11/2328/03/24----

Upcoming sector events for Galena Biopharma Inc

Today 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Galena Biopharma Inc

Today JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
Today BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
Today PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
Today REMEGEN CO., LTD.: Q1 2024 Earnings Release (Projected)
Today HITGEN INC.: Q4 2023 Earnings Release
2024-04-24 04:05 pm VIKING THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-23 INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23 SINOCELLTECH GROUP LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23 SHANGHAI MEDICILON INC.: Q4 2023 Earnings Release
2024-04-23 07:30 am KINIKSA PHARMACEUTICALS, LTD.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. SLS Stock
  4. Stock
  5. Calendar Galena Biopharma Inc